martes, 26 de abril de 2011

WHO Pharmaceuticals Newsletter (No. 2, 2011)

Esta disponible el WHO Pharmaceuticals Newsletter (No. 2, 2011) con el siguiente contenido:

Regulatory Matters
Antipsychotics ........1
Buflomedil ............1
Dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists . 1
Dronedarone ........ 2
Lopinavir/ritonavir....... 3
Methylene blue injectable..... 3
Modafinil ..................... 4
Proton pump inhibitors.........4
Rosiglitazone ............. 5
Rotavirus vaccination........... 6
Sitaxentan ............ 6
Terbutaline........ 7
Topiramate........... 7

Safety of Medicines
Abacavir ............... 9
Colchicine ............. 9
Daptomycin........... 9
Dronedarone ..........10
H1N1 influenza vaccine (Pandemrix).................. 10
Lenalidomide .............11
Natalizumab ............12
Omalizumab ............................... 12
Seasonal influenza vaccine ............... 12

Feature
WHO Training Course on Pharmacovigilance ............. 14

proximamente disponible en:
http://www.who.int/medicines/publications/newsletter/en/index.html